Press Releases

ABPI Code Introduced New Requirements For Working With Health Professionals And Patient Groups More detailed requirements for pharmaceutical companies’ relationships with patient groups and health Read more...

Prescription drug ads need more oversight to protect patients AMA President-elect testifies to Congress on direct-to-consumer advertising For immediate release May 8, 2008 WASHINGTON, DC - Today, Read more...

Schweizerhall: Impending Approval of Clopidogrel from Cimex in Germany BASLE, Switzerland, May 8, 2008. 18.00 hrs. --- The decentralized approval procedure of clopidogrel developed by Cimex AG Read more...

FDA Delays Decision on Adolor Corporation, GlaxoSmithKline (GSK) Bowel Drug EXTON, Pa. -- Adolor Corporation (Nasdaq:ADLR - News) announced today that the U.S. Food and Drug Administration (FDA) has Read more...

FDA Grants Priority Review of Talecris Biotherapeutics's Gamunex as a Treatment for Neurological Disorder CIDP RESEARCH TRIANGLE PARK, N.C. -- Talecris Biotherapeutics, Inc. announced today the U.S. Read more...

Spectrum Pharmaceuticals Announces Sale of Injectable Generic Drugs to Sagent Pharmaceuticals IRVINE, Calif. -- Spectrum Pharmaceuticals, Inc.,: Spectrum Pharmaceuticals, Inc., announced today that Read more...

DOYLESTOWN, Pennsylvania and OXFORD, England, May 9 /PRNewswire/ -- EUSA Pharma Inc ('EUSA'), a transatlantic specialty pharmaceutical company focused on oncology, pain control and critical care, Read more...

OSAKA, Japan, and CAMBRIDGE, Mass., May 9 /PRNewswire-FirstCall/ -- Takeda Pharmaceutical Company Limited, "Takeda", (TSE: 4502) and Millennium Pharmaceuticals, Inc., "Millennium" (Nasdaq: MLNM) Read more...

BETHESDA, Md., May 9 /PRNewswire-FirstCall/ -- Northwest Biotherapeutics, Inc. (AIM: NWBS and NWBT; OTC Bulletin Board: NWBO), today announced that Al Rajhi Holdings W.L.L. ("Al Rajhi") has entered Read more...

NUTLEY, N.J., May 9 /PRNewswire/ -- Roche today announced one-year results from a new two-year Phase III study showing that ACTEMRA(TM) (tocilizumab) can significantly inhibit progression of Read more...

SAN DIEGO, May 8 /PRNewswire-FirstCall/ -- NuVasive, Inc. (Nasdaq: NUVA), a medical device company focused on developing products for minimally disruptive surgical treatments for the spine, announced Read more...

FDA Advisory Committee Votes in Favor of Approval of Fospropofol Disodium Injection for Sedation Woodcliff Lake, NJ - May 7, 2008 - Eisai Corporation of North America and its U.S. subsidiary, MGI Read more...

Accordance with Terms of Existing Investor Rights Agreement CAMBRIDGE, Mass. -- May 8, 2008--Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that Novartis has Read more...

FDA Approves Strattera for Maintenance of ADHD in Children and Adolescents First Medication Indicated for Maintenance Treatment for ADHD May 08, 2008: 09:52 AM EST Eli Lilly and Company (NYSE: LLY) Read more...

Biovail Announces New Strategic Focus TORONTO -- May 8, 2008 - Biovail Corporation today announced several new initiatives stemming from its strategic review, including a new strategic focus on Read more...